MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Levocarb-induced diplopia in idiopathic Parkinson’s disease: a case report

    S. Joza, F. Ba (Edmonton, AB, Canada)

    Objective: To present a case report of Levocarb-induced diplopia in idiopathic Parkinson’s disease. Background: Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by a…
  • 2019 International Congress

    Levodopa/carbidopa Intestinal Gel in Treatment of Non-Motor Symptoms in Advanced Parkinson’s Disease

    W. Kamel, J. Al Hashel (Beni Suef, Egypt)

    Objective: To identify the advantages of LCIG in the treatment of NMS among APD patients and appraise the currently available literature to identify the gaps…
  • 2019 International Congress

    The influence of baseline body mass index on cognitive decline in Parkinson’s disease

    SY. Kang, HS. Yoo, SJ. Chung, YH. Sohn, PH. Lee (Seoul, Republic of Korea)

    Objective: The aim of this study is to know whether the baseline BMI is associated with cognitive decline and future development of dementia. Background: Alterations…
  • 2019 International Congress

    Subacute Encephalopathy with Pimavanserin Treatment in Parkinson Disease

    J. King, G. Volkell, J. Wyant, E. Molho (Albany, NY, USA)

    Objective: To report 3 cases of drug-induced encephalopathy in patients treated with pimavanserin (PVN) for Parkinson disease (PD) related psychosis (PDP). Background: Quetiapine and clozapine,…
  • 2019 International Congress

    A Prospective Study of the Effects of Deep Brain Stimulation on Constipation and Olfaction in Parkinson Disease

    S. Kola, A. Bharucha, D. Prichard, K. Feuerhak, A. Hassan (Rochester, MN, USA)

    Objective: To investigate the effects of subthalamic nucleus deep brain stimulation (STN-DBS) on constipation and olfaction in patients with Parkinson disease (PD). Background: STN-DBS is…
  • 2019 International Congress

    Cognitive impairment in patients with Parkinson’s Disease

    E. Kolupaeva, I. Zhukova, N. Zhukova, M. Nikitina, O. Izhboldina, I. Mironova, Z. Kislukhina (Tomsk, Russian Federation)

    Objective: The objective is to study the relation between cognitive impairment with the form and stage of PD. Background: Currently, there is a tendency of…
  • 2019 International Congress

    Evaluation of gut microbiota in patients with Parkinson’s disease using a gas chromatography–mass spectrometry in Russia

    I. Krasakov, I. Litvinenko (Saint-Petersburg, Russian Federation)

    Objective: To evaluat of gut microbiota in patients with Parkinson's disease using a gas chromatography–mass spectrometry Background: An increasing number of studies have reported the…
  • 2019 International Congress

    The social interaction in patients with Parkinson’s disease from the points of activities of daily living and motor function

    A. Kumon, M. Sagawa, M. Saruwatari, N. Kawashima, K. Hasegawa (Fujisawa, Japan)

    Objective: To investigate how the social interaction relates to activities of daily living (ADL) and motor function in patients with Parkinson’s disease (PD). Background: In…
  • 2019 International Congress

    Exploring the relationship between motor and non-motor fluctuations in Parkinson’s disease: patient’s perspective, clinician’ s assessment and objective measures from a wearable device

    A. Leake, A. de Angelis, M. Horne, D. Paviour, J. Coebergh, M. Edwards, F. Morgante, L. Ricciardi (London, United Kingdom)

    Objective: We aimed: 1) To evaluate the relationship between motor (MF) and non-motor (NMF) fluctuations in Parkinson’s disease measured with patient’s self-assessment, clinician’s evaluationand objective measurement using a wearable…
  • 2019 International Congress

    Predictors of refractory impulse control disorder to dopamine agonists substitution therapy in Parkinson’s disease patients

    JY. Lee, J-H. Choi, B. Jeon, J. Cho (Seoul, Republic of Korea)

    Objective: This study was aimed to investigate a predictive factor of refractory impulse control disorder (ICD) in patients with Parkinson’s disease (PD) who participated in…
  • « Previous Page
  • 1
  • …
  • 1179
  • 1180
  • 1181
  • 1182
  • 1183
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley